Clinical Trial Update: A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing Leucogen to placebo for management of leukocyte and platelet counts during PFLL chemotherapy in stage IV, recurrent or meta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Leucogen

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma, Leucogen | Phase 3 | Status: NOT_YET_RECRUITING